<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Min JG</submitter><funding>Korea Institute of Marine Science and Technology Promotion</funding><pagination>680</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11209460</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(6)</volume><pubmed_abstract>Red seabream iridovirus (RSIV) is a major cause of marine fish mortality in Korea, with no effective vaccine available since its first occurrence in the 1990s. This study evaluated the efficacy of a formalin-killed vaccine against RSIV in rock bream under laboratory and field conditions. For the field trial, a total of 103,200 rock bream from two commercial marine cage-cultured farms in Southern Korea were vaccinated. Farm A vaccinated 31,100 fish in July 2020 and monitored them for 18 weeks, while farm B vaccinated 30,700 fish in August 2020 and monitored them for 12 weeks. At farm A, where there was no RSIV infection, the vaccine efficacy was assessed in the lab, showing a relative percentage of survival (RPS) ranging from 40% to 80%. At farm B, where natural RSIV infections occurred, cu</pubmed_abstract><journal>Vaccines</journal><pubmed_title>Evaluation of Formalin-Inactivated Vaccine Efficacy against Red Seabream Iridovirus (RSIV) in Laboratory and Field Conditions.</pubmed_title><pmcid>PMC11209460</pmcid><funding_grant_id>00236096</funding_grant_id><pubmed_authors>Kim CH</pubmed_authors><pubmed_authors>Min JG</pubmed_authors><pubmed_authors>Kim GH</pubmed_authors><pubmed_authors>Kwon WJ</pubmed_authors><pubmed_authors>Kim KI</pubmed_authors><pubmed_authors>Jeong HD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of Formalin-Inactivated Vaccine Efficacy against Red Seabream Iridovirus (RSIV) in Laboratory and Field Conditions.</name><description>Red seabream iridovirus (RSIV) is a major cause of marine fish mortality in Korea, with no effective vaccine available since its first occurrence in the 1990s. This study evaluated the efficacy of a formalin-killed vaccine against RSIV in rock bream under laboratory and field conditions. For the field trial, a total of 103,200 rock bream from two commercial marine cage-cultured farms in Southern Korea were vaccinated. Farm A vaccinated 31,100 fish in July 2020 and monitored them for 18 weeks, while farm B vaccinated 30,700 fish in August 2020 and monitored them for 12 weeks. At farm A, where there was no RSIV infection, the vaccine efficacy was assessed in the lab, showing a relative percentage of survival (RPS) ranging from 40% to 80%. At farm B, where natural RSIV infections occurred, cu</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-04-07T22:48:39.366Z</modification><creation>2025-04-04T21:22:23.963Z</creation></dates><accession>S-EPMC11209460</accession><cross_references><pubmed>38932409</pubmed><doi>10.3390/vaccines12060680</doi></cross_references></HashMap>